These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 1345335)

  • 1. Hypertension, hyperlipidemia, insulin resistance and obesity: parts of a metabolic syndrome.
    Lind L; Lithell H
    Blood Press Suppl; 1992; 4():49-54. PubMed ID: 1345335
    [No Abstract]   [Full Text] [Related]  

  • 2. [Metabolic syndrome with vascular risk and arterial hypertension].
    Wassermann AO; Grosso CP
    Medicina (B Aires); 1996; 56(2):183-94. PubMed ID: 8935572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Visceral fat syndrome].
    Tokunaga K; Nakamura T; Kubo M; Matsuzawa Y
    Nihon Naika Gakkai Zasshi; 1992 Nov; 81(11):1831-5. PubMed ID: 1479226
    [No Abstract]   [Full Text] [Related]  

  • 4. Hypertension: a new perspective in therapy and metabolic effect. Part I.
    Medina Ruiz A
    Bol Asoc Med P R; 1991 Sep; 83(9):399-401. PubMed ID: 1807274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Insulin resistance and metabolic anomalies associated with hypertension and overweight].
    Vague P
    Rev Prat; 1994 Sep; 44(13 Suppl):46-8. PubMed ID: 8091114
    [No Abstract]   [Full Text] [Related]  

  • 6. [Obesity and insulin resistance--risk factors and parts of metabolic syndrome].
    Mel'nichenko GA; Pyshkina EA
    Ter Arkh; 2001; 73(12):5-8. PubMed ID: 11858109
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of doxazosin on insulin resistance in hypertensive patients with obesity.
    Ueshiba H; Miyachi Y
    Horm Metab Res; 2003 Sep; 35(9):532-6. PubMed ID: 14517769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Role of abdominal obesity in pathogenesis of insulin resistance syndrome].
    Almazov VA; Blagosklonnaia IaV; Shliakhto EV; Krasil'nikova EI
    Ter Arkh; 1999; 71(10):18-22. PubMed ID: 10612167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The metabolic syndrome].
    Ratzmann KP
    Z Arztl Fortbild (Jena); 1991 Jul; 85(14):651-6. PubMed ID: 1926931
    [No Abstract]   [Full Text] [Related]  

  • 10. [Assessment of selected markers of inflammation in patients with clinical symptoms of insulin resistance and normal renal function].
    Bogdański P; Pupek-Musialik D; Luczak M; Szulińska M
    Pol Merkur Lekarski; 2006 Aug; 21(122):165-8; discussion 169. PubMed ID: 17144103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of obesity in primary hyperlipidemias.
    Carmena R; Ascaso JF; Real JT
    Nutr Metab Cardiovasc Dis; 2001 Oct; 11(5):354-9. PubMed ID: 11887432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The metabolic syndrome: common etiology for distinct cardiovascular risk factors?].
    Weisser B; Locher R; Vetter W
    Schweiz Rundsch Med Prax; 1993 Nov; 82(47):1339-43. PubMed ID: 8272698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The insulin resistance syndrome: mechanisms of clustering of cardiovascular risk.
    Chan JC; Tong PC; Critchley JA
    Semin Vasc Med; 2002 Feb; 2(1):45-57. PubMed ID: 16222595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The insulin resistance syndrome.
    Smolar EN
    Compr Ther; 1997 Apr; 23(4):237-43. PubMed ID: 9167914
    [No Abstract]   [Full Text] [Related]  

  • 15. Hypertension as a metabolic disorder--an overview.
    Smith U; Gudbjörnsdottir S; Landin K
    J Intern Med Suppl; 1991; 735():1-7. PubMed ID: 2043218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Syndrome "X"].
    Chabot V
    Schweiz Rundsch Med Prax; 1993 Aug; 82(32):858-63. PubMed ID: 8372281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levels of C3 in patients with severe, morbid and extreme obesity: its relationship to insulin resistance and different cardiovascular risk factors.
    Hernández-Mijares A; Jarabo-Bueno MM; López-Ruiz A; Solá-Izquierdo E; Morillas-Ariño C; Martínez-Triguero ML
    Int J Obes (Lond); 2007 Jun; 31(6):927-32. PubMed ID: 17264851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin resistance and hypertension in the absence of subcutaneous fat.
    Chaudhuri A; Izzo JL
    Rev Cardiovasc Med; 2000; 1(2):120-4. PubMed ID: 12457148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The clinical implications of insulin resistance.
    Peters AL
    Am J Manag Care; 2000 Aug; 6(13 Suppl):S668-74; discussion S675-81. PubMed ID: 11183420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Childhood obesity increases the risk of coronary artery disease].
    Nuutinen O; Nuutinen M
    Duodecim; 2001; 117(13):1356-62. PubMed ID: 12184126
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.